Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.01 | uM | 8 | 625.00 | 270.83 | 290.00 | 597.75 | 0.4852 | 0.0617 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 625.00 | 270.83 | 640.00 | 597.75 | 1.0707 | 1.1232 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 625.00 | 270.83 | 748.00 | 597.75 | 1.2514 | 1.4338 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 625.00 | 270.83 | 276.00 | 597.75 | 0.4617 | 0.0167 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 625.00 | 270.83 | 631.00 | 597.75 | 1.0556 | 1.0971 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 625.00 | 270.83 | 613.00 | 597.75 | 1.0255 | 1.0446 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 625.00 | 270.83 | 706.00 | 597.75 | 1.1811 | 1.3138 |
| BT-20 | Lapatinib | 1 | uM | 8 | 625.00 | 270.83 | 567.00 | 597.75 | 0.9486 | 0.9096 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 576.00 | 597.75 | 0.9636 | 0.9361 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 446.00 | 597.75 | 0.7461 | 0.5477 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1124.00 | 1551.25 | 0.7246 | 0.5659 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1483.00 | 1551.25 | 0.9560 | 0.9328 | |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 1221.00 | 1551.25 | 0.7871 | 0.6675 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 1250.00 | 622.75 | 1112.00 | 1551.25 | 0.7168 | 0.5532 |
| BT-20 | Linsitinib | 10 | uM | 8 | 1250.00 | 622.75 | 1279.00 | 1551.25 | 0.8245 | 0.7273 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 1664.00 | 1551.25 | 1.0727 | 1.1095 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 1250.00 | 622.75 | 1229.00 | 1551.25 | 0.7923 | 0.6758 |
| BT-20 | Erlotinib | 1 | uM | 8 | 1250.00 | 622.75 | 1770.00 | 1551.25 | 1.1410 | 1.2108 |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 1250.00 | 622.75 | 1569.00 | 1551.25 | 1.0114 | 1.0174 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1856.00 | 1551.25 | 1.1965 | 1.2919 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 1250.00 | 622.75 | 1725.00 | 1551.25 | 1.1120 | 1.1679 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 2018.00 | 1551.25 | 1.3009 | 1.4423 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 1250.00 | 622.75 | 2010.00 | 1551.25 | 1.2957 | 1.4349 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 1250.00 | 622.75 | 1775.00 | 1551.25 | 1.1442 | 1.2155 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1910.00 | 1551.25 | 1.2313 | 1.3423 |